Clinical Trial Update: Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating U101 oral capsules to prevent uncomplicated recurrent urinary tract infections in women is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infections

Drugs mentioned

• U101

Snippet

Sponsor: TCM Biotech International Corp. | Conditions: Recurrent Urinary Tract Infections in Women | Phase 3 | Status: RECRUITING